Bioventus Inc. (BVS): M&A transaction — Bioventus completes divestiture of Advanced Rehab business to Accelmed for $25M cash plus $20M earn-out

Bioventus Inc.

Closed sale of Advanced Rehabilitation business to Accelmed Partners on Dec 31, 2024.
Received $25M cash at closing, subject to working capital adjustments.
Up to $20M in earn-out payments based on 2025-2026 revenue and EBITDA thresholds.
Net closing proceeds of approx $20M to enhance liquidity; company to focus on core businesses.
Accelmed is a private equity firm focused on commercial-stage HealthTech companies.

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Bioventus Inc. completed a disposition involving Rehab Acquisition Corporation, III (now known as Bioness Medical, Inc.) for $25.0 million (closed 2024-12-31).

Action: disposition
Counterparty: Rehab Acquisition Corporation, III (now known as Bioness Medical, Inc.)
Consideration: $25.0 million
Closing: 2024-12-31

Exact text from the filing

On December 31, 2024 , the Transaction closed (the “Closing”) and the Sellers received a cash payment of $25.0 million subject to customary post-closing adjustments for working capital.

View on SEC.gov

Browse all m&a transactions →

Bioventus Inc. filing history →

Source: SEC EDGAR

accession 0001628280-25-000253

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.